11 reports

GLOBAL IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026 ##.

  • Immunohistochemistry
  • In Vitro Diagnostics
  • World
  • Market Size

Global Laboratory Reagents Industry LABORATORY REAGENTS MCP-## A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS ##.

  • Immunohistochemistry
  • APAC
  • Japan
  • United States
  • World

ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026 ##.

  • Immunohistochemistry
  • APAC
  • Market Size

Increasing cases of cancer in the country is one of the major reasons for the growth of the market in the country.

  • Immunohistochemistry
  • In Vitro Diagnostics
  • North America
  • Market Size

CANCER ##. ##. ##. ##.

  • Immunohistochemistry
  • In Vitro Diagnostics
  • Europe
  • Market Size

Cancer has high morbidity and mortality risk.

  • Immunohistochemistry
  • United States
  • Demand
  • Market Size

CANCER ##. ##. ##. ##.

  • Immunohistochemistry
  • In Vitro Diagnostics
  • Latin America
  • Market Size

Strategic initiatives List of Tables ##.

  • Immunohistochemistry
  • In Vitro Diagnostics
  • United States
  • Demand
  • Market Size
  • IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN
  • ITALY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)

According to a MHLW report in 2017, cancer control is one of the policy of the Health Service Bureau; increasing the rate of cancer screening is one of the major objectives of the bureau.

  • Immunohistochemistry
  • North America
  • United States
  • Market Size
  • Agilent Technologies, Inc.
  • is expected to reach 21.7 million by 2030; in 2012, 8.2 million cancer-related deaths were recorded
  • GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE FOR CANCER DIAGNOSIS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)

The immunohistochemistry (IHC) market is projected to reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period of 2016 to 2021. Factors such as the growing prevalence of cancer and rapidly increasing geriatric population across the globe are the primary driving the growth of this market. Other factors driving the...

  • Immunohistochemistry
  • North America
  • United States
  • World
  • Market Size
  • Immunohistochemistry Based Companion Diagnostic Kit - MTX5 - Product Description
  • Immunohistochemistry Based Companion Diagnostic Kit - MTX3 - Product Description

Summary Oncomatryx Biopharma SL (Oncomatryx) is a developer of precision drugs.The company offers precision drugs that targets proteins located in the tumor environment. It develops therapeutic antibody-drug conjugates, antibodies, and human-derived proteins, which targets tumor associated stroma.Oncomatryx’s products...

  • Immunohistochemistry
  • In Vitro Diagnostics
  • United States
  • Company
  • Product Initiative